Research from tobacco industry affiliated authors: Need for particular vigilance

Tobacco Control

Volumn 14, Issue 4, 2005, Pages 217-219

  Chapman, S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CONFLICT OF INTEREST; EDITORIAL; ETHICS; FINANCIAL MANAGEMENT; HUMAN; PUBLICATION; RESEARCH ETHICS; SCIENTIFIC MISCONDUCT; TOBACCO INDUSTRY;

CONFLICT OF INTEREST; ETHICS, RESEARCH; HUMANS; PERIODICALS; RESEARCH SUPPORT; SCIENTIFIC MISCONDUCT; TOBACCO INDUSTRY;

EID: 23744493131     PISSN: 09644563     EISSN: None     Source Type: Journal    
DOI: 10.1136/tc.2005.012427     Document Type: Editorial

References (43)

1. Yano E. Japanese spousal smoking study revisited: how a tobacco industry funded paper reached erroneous conclusions. Tobacco Control 2005;14:227-33.
2. Hong MK, Bero LA. How the tobacco industry responded to an influential study of the health effects of secondhand smoke. BMJ 2002;325:1413-6.
3. Lee PN. Japanese spousal study: a response to Professor Yano's claims. Tobacco Control 2005;14:233-4.
4. Covington & Burling. Proposal for an applied research study to investigate exposure to environmental tobacco smoke in non-smoking Japanese women. August 1991. http://legacy.library.ucsf.edu/tid/jpn34e00.
5. Boyse S. (BAT) Note on a special meeting of the UK industry on environmental tobacco smoke, London. Feb 17 1988 http://legacy.library.ucsf.edu/ tid/kur45d00.
6. World Association of Medical Editors. Ghost writing initiated by commercial companies. http://www.wame.org/wamestmt.htm#ghost.
7. Lee PN. "Marriage to a smoker" may not be a valid marker of exposure in studies relating environmental tobacco smoke to risk of lung cancer in Japanese non-smoking women. Int Arch Occup Environ Health 1995;67:287-94.
8. Bero L, Barnes DE, Hanauer P, et al. Lawyer control of the tobacco industry's external research program. The Brown and Williamson documents. JAMA 1995;274:241-7.
9. Assunta M, Fields N, Knight J, et al. "Care and feeding": the Asian environmental tobacco smoke consultants programme. Tobacco Control 2004;13(suppl II):ii4-12.
10. Barnoya J, Glantz S. Tobacco industry success in preventing regulation of secondhand smoke in Latin America: the "Latin Project". Tobacco Control 2002;11:305-14.
11. Muggli ME, Hurt RD, Blanke DD. Science for hire: a tobacco industry strategy to influence public opinion on secondhand smoke. Nicotine Tob Res 2003;5:303-14.
12. McKee M. Competing interests: the importance of transparency. Eur J Public Health 2003;13:193-4.
13. Diethelm PA, Rielle J-C, McKee M. Authors' reply. Lancet 2005;365:211-2.
14. Chapman S, Penman A. "Can't stop the boy": Philip Morris' use of Healthy Buildings International to prevent workplace smoking bans in Australia. Tobacco Control 2003;12(suppl III):iii107-12.
15. Rupp JP, Billings DM. Asia ETS Consultant Status Report. 14 Feb 1990. Philip Morris. Bates No. 2500048976/8998. http://legacy.library. ucsf.edu/tid/zzd58d00.
16. Barnes DE, Bero LA. Scientific quality of original research articles on environmental tobacco smoke. Tobacco Control 1997;6:19-26.
17. Hirayama T. Non-smoking wives of heavy smokers have a higher risk of lung cancer: a study from Japan. BMJ 1981;282:183-5.
18. Chilcote S. Public smoking: the problem (speech). Undated. Bates No. TIMN 0014554-4565. http://tobaccodocuments.org/ti/TIMN0014554-4565.html.
19. Chapman S, Borland R, Scollo M, et al. The impact of smoke-free workplaces on declining cigarette consumption in Australia and the United States. Am J Public Health 1999;89:1018-23.
20. Fichtenberg CM, Glantz SA. Effect of smoke-free workplaces on smoking behaviour: systematic review. BMJ 2002;325:188.
21. Goodin R. The ethics of smoking. Ethics 1989;99:574-624.
22. Anon. Report of the inquiry into the case involving Prof. Ragner Rylander. (unofficial translation). Geneva, Sept 6 2004. http://www.prevention. ch/rye060904.pdf.
23. Republic and Canton of Geneva. The Judiciary.P/542/01 ACJP/223/03. Decision of the Court of Appeal Criminal Division Hearing of Monday 15 December 2003 http://www.prevention.ch/ryjue151203.htm.
24. Liberman J. The shredding of BAT's defence: McCabe v British American Tobacco Australia. Tobacco Control 2002;11:271-4.
25. A-Jeri KK, Chan A-W, Dickersin K, et al. Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). BMJ 2005;330:956-8.
26. Cummings KM, Morley CP, Horan JK, et al. Marketing to America's youth: evidence from corporate documents. Tobacco Control 2002;11(suppl I):i5-17.
27. Vagg R, Chapman S. Nicotine analogues: a review of tobacco industry research interests. Addiction 2005;100:701-12.
28. Webb W. (Philip Morris) Status of Marlboro development program. July 12 1984. http://legacy.library.ucsf.edu/tid/gmr98e00.
29. Boddewyn JJ. There is no convincing evidence for a relationship between cigarette advertising and consumption. Br J Addiction 1989;84:1255-61.
30. Chapman S, Carter SM. "Avoid health warnings on all tobacco products for just as long as we can": a history of Australian tobacco industry efforts to avoid, delay and dilute health warnings on cigarettes. Tobacco Control 2003;12(suppl III):iii13-22.
31. Landman A, Ling PM, Glantz SA. Tobacco industry youth smoking prevention programs: protecting the industry and hurting tobacco control. Am J Public Health 2002;92:917-30.
32. Fields N, Chapman S. Chasing Ernst L Wynder: 40 years of Philip Morris' efforts to influence a leading scientist. J Epidemiol Community Health 2003;57:571-8.
33. Foulds J, Ramstrom L, Burke M, et al. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tobacco Control 2003;12:349-59.
34. Gray N, Boyle P. The case of the disappearing nitrosamines: a potentially global phenomenon. Tobacco Control 2004;13:13-16.
35. Irwin D. Costing the earth - BBC programme [memo] 2 May 2000. Bates 325153707. http://tobacco.health.usyd.edu.au/tds/BAT325153707.
36. Wynder EL, Hoffman D. Reduction of tumorigenicity of cigarette smoke: an experimental approach. JAMA 1965;192:88-94.
37. Marks DF. A higher principle is at stake than simply freedom of speech. BMJ 1996;312:773-4.
38. Rutter T. US journals veto tobacco funded research. BMJ 1996;312:11.
39. King J, Yamey G, Smith R. For and against: why journals should not publish articles funded by the tobacco industry. BMJ 2000;321:1074-6.
40. Lexchin J, Bero LA, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167-70.
41. Levine J, Gussow JD, Hastings D, et al. Authors' financial relationships with the food and beverage industry and their published positions on the fat substitute olestra. Am J Public Health 2003;93:664-9.
42. Garne D, Watson M, Chapman S, et al. Environmental tobacco smoke research published in the journal Indoor and Built Environment and associations with the tobacco industry. Lancet 2005;365:804-9.
43. Bero LA, Glantz S, Hong MK. The limits of competing interest disclosures. Tobacco Control 2005;14:118-26.